Brooks Laboratories Stock Screener | Share Price & Fundamental Analysis
BROOKS
Pharmaceuticals
Screen Brooks Laboratories share price with our stock screener - analyze fundamentals and track trades in your journal
Share Price NSE
₹74.71
▼
-1.13 (-1.49%)
Share Price BSE
₹75.22
▼
-0.79 (-1.04%)
Market Cap
₹227.59 Cr.
P/E Ratio (TTM)
15.00
P/B Ratio
1.97
EPS (TTM)
₹-3.72
Dividend Yield
-
Debt to Equity
0.08
52W High
₹160.19
52W Low
₹70.90
Operating Margin
-5.00%
Profit Margin
-8.33%
Revenue (TTM)
₹24.00
EBITDA
₹-1.00
Net Income
₹-2.00
Total Assets
₹124.00
Total Equity
₹98.00
Brooks Laboratories Share Price History - Stock Screener Chart
Screen BROOKS historical share price movements with interactive charts. Analyze price trends and patterns.
Brooks Laboratories Company Profile - Fundamental Screener
Screen Brooks Laboratories company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for BROOKS shares.
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
ISIN
INE650L01011
Brooks Laboratories Balance Sheet Screener - Fundamental Analysis
Fair Value AnalysisScreen BROOKS balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Assets | |||||
| Total Assets | 124 | 90 | 110 | 196 | 162 |
| Current Assets | 34 | 31 | 28 | 61 | 47 |
| Fixed Assets | 14 | 14 | 15 | 110 | 108 |
| Liabilities | |||||
| Total Liabilities | 124 | 90 | 110 | 196 | 162 |
| Current Liabilities | 3 | 2 | 3 | 13 | 19 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | |||||
| Total Equity | 98 | 66 | 74 | 134 | 79 |
| Share Capital | 30 | 26 | 25 | 25 | 25 |
| Reserves & Surplus | 69 | 39 | 49 | 63 | 54 |
Screen BROOKS income statement and profit fundamentals. Analyze revenue growth, EBITDA, net profit margins, and EPS using our fundamental screener for share price evaluation.
| Item | 2025-Mar | 2025-Jun | 2025-Sept | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec | 2023-Mar | 2023-Jun | 2023-Sept | 2023-Dec | 2022-Mar | 2022-Jun | 2022-Sept | 2022-Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 24 | 33 | 30 | 18 | 18 | 21 | 21 | 13 | 16 | 24 | 22 | 29 | 17 | 19 | 16 |
| Expenses | 25 | 22 | 21 | 27 | 20 | 24 | 22 | 16 | 20 | 25 | 25 | 32 | 26 | 27 | 24 |
| EBITDA | -1 | 10 | 9 | -9 | -2 | -3 | -2 | -4 | -4 | -1 | -3 | -4 | -9 | -9 | -8 |
| Operating Profit % | -5.00% | 12.00% | 11.00% | -54.00% | -11.00% | -16.00% | -7.00% | -29.00% | -25.00% | -5.00% | -15.00% | -14.00% | -50.00% | -51.00% | -56.00% |
| Depreciation | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 2 | 2 | 2 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 |
| Profit Before Tax | -1 | 10 | 8 | -10 | -2 | -4 | -2 | -4 | -5 | -2 | -4 | -7 | -11 | -12 | -11 |
| Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1 | -2 | -4 | -2 |
| Net Profit | -2 | 10 | 8 | -10 | -2 | -4 | -2 | -4 | -5 | -2 | -4 | -6 | -9 | -8 | -10 |
| EPS | -0.54 | 3.25 | 2.71 | -3.77 | -0.94 | -1.51 | -1.75 | -1.75 | -1.81 | -0.60 | -1.51 | -1.46 | -3.80 | -3.19 | -2.03 |
Brooks Laboratories Cash Flow Screener - Liquidity Fundamentals
Screen BROOKS cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March |
|---|---|---|---|---|---|
| Operating Activities | 3 | -10 | -15 | -37 | 5 |
| Investing Activities | -45 | 0 | 1 | -25 | -5 |
| Financing Activities | 42 | 10 | 11 | 64 | 1 |
| Net Cash Flow | 0 | 0 | -3 | 2 | 1 |
Screen BROOKS shareholding pattern and ownership fundamentals. Analyze promoter holding, institutional investors, and share distribution using our screener for informed investment decisions.
| Item | 2025-Jan | 2025-Mar | 2025-Jun | 2025-Sept | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 52.62% | 52.62% | 52.62% | 52.62% | 63.59% | 63.59% | 63.59% | 59.06% |
| FII Holding | 0.00% | 0.05% | 0.00% | 0.01% | 0.00% | 0.00% | 0.02% | 0.01% |
| DII Holding | 9.90% | 10.38% | 10.38% | 10.38% | 3.86% | 3.86% | 3.86% | 3.86% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 32.13% | 31.86% | 32.01% | 31.70% | 25.55% | 25.57% | 28.55% | 32.34% |
| Other Holding | 5.35% | 5.08% | 4.99% | 5.30% | 7.00% | 6.98% | 3.99% | 4.74% |
| Shareholder Count | 10,374 | 10,537 | 10,317 | 10,078 | 11,432 | 11,543 | 11,282 | 10,521 |
Brooks Laboratories Dividend Screener - Share Yield Analysis
Screen BROOKS dividend history and yield fundamentals. Analyze dividend payout, frequency, and returns using our stock screener for income-focused share price evaluation.
Brooks Laboratories Index Membership - Market Screener Classification
Screen BROOKS by index membership and market classification. Filter stocks by major indices like NIFTY, SENSEX using our screener for systematic share price tracking.
Brooks Laboratories Market Events Screener - Corporate Actions
Screen BROOKS market events and corporate actions affecting share price. Track splits, bonuses, buybacks, and major announcements using our stock screener for fundamental event analysis.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| Annual General Meeting | NA | 25.21% | ||
| Annual General Meeting | NA | 6.27% | ||
| Annual General Meeting | NA | -5.83% | ||
| 2025-11-14 | 2025-11-14 | Quarterly Result Announcement | NA | 3.90% |
| 2025-08-13 | 2025-08-13 | Quarterly Result Announcement | NA | -4.69% |
| 2025-05-28 | 2025-05-28 | Quarterly Result Announcement | NA | -3.00% |
| 2025-02-13 | 2025-02-13 | Quarterly Result Announcement | NA | -12.64% |
| 2025-01-11 | 2025-01-11 | Extraordinary General Meeting | NA | 15.99% |
| 2024-11-09 | 2024-11-09 | Quarterly Result Announcement | NA | -4.13% |
| 2023-07-28 | 2023-07-28 | Rights | 1:16 | 12.52% |
| 2020-02-11 | Rights | 9:20 | - |
Brooks Laboratories Competitors Screener - Peer Comparison
Screen BROOKS competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 414,605 | 39.37 | 54,729 | 9.71% | 10,980 | 42.10 |
| Divis Laboratories | 169,701 | 67.76 | 9,712 | 18.67% | 2,191 | 48.20 |
| Torrent Pharmaceuticals | 131,496 | 60.85 | 11,539 | 6.99% | 1,911 | 67.66 |
| Cipla | 122,103 | 22.30 | 28,410 | 7.12% | 5,291 | 51.10 |
| Dr Reddys Laboratories | 104,838 | 18.24 | 33,741 | 16.73% | 5,725 | 45.31 |
| Lupin | 96,170 | 22.10 | 22,910 | 13.74% | 3,306 | 56.06 |
| Zydus Life Science | 92,262 | 18.30 | 23,511 | 18.55% | 4,615 | 45.37 |
| Mankind Pharma | 90,929 | 50.34 | 12,744 | 20.90% | 2,007 | 50.55 |
| Aurobindo Pharma | 70,591 | 20.25 | 32,346 | 9.43% | 3,484 | 56.45 |
| Alkem Laboratories | 66,867 | 27.11 | 13,458 | 3.70% | 2,216 | 50.91 |
Brooks Laboratories Company Announcements - News Screener
Screen BROOKS latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2025-12-30 | Closure of Trading Window | View |
| 2025-11-15 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-11-14 | Board Meeting Outcome for Outcome Of The Board Meeting Held On Friday 14Th November 2025. | View |
| 2025-11-14 | Results For Quarter And Half Year Ended 30Th September 2025 | View |
| 2025-11-12 | Announcement under Regulation 30 (LODR)-Credit Rating | View |
| 2025-11-07 | Board Meeting Intimation for Regulation 29 Of SEBI (Listing Obligation And Disclosure Requirements) Regulations 2015 | View |
| 2025-10-16 | Announcement under Regulation 30 (LODR)-Change in Management | View |
| 2025-10-09 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | View |
| 2025-09-27 | Shareholder Meeting / Postal Ballot-Scrutinizers Report | View |
| 2025-09-27 | Closure of Trading Window | View |
| 2025-09-26 | Merger Of Brooks Steriscience Limited (BSL) A Joint Venture/Associate Of The Company Through A Composite Scheme Of Arrangement And Amalgamation (Merger By Absorption). | View |
| 2025-09-26 | Announcement under Regulation 30 (LODR)-Change in Management | View |
| 2025-09-26 | Shareholder Meeting / Postal Ballot-Outcome of AGM | View |
| 2025-09-10 | Intimation Of Record Date E-Voting Dates And Book Closure Date | View |
| 2025-09-06 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-09-04 | Letter To The Shareholders - Annual Report For The FY 2024-25. | View |
| 2025-09-04 | Shareholder Meeting- AGM On 26Th September 2025. | View |
| 2025-09-04 | Reg. 34 (1) Annual Report. | View |
| 2025-09-02 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-09-01 | Announcement under Regulation 30 (LODR)-Amendments to Memorandum & Articles of Association | View |